Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Busulfan effect on left ventricular global longitudinal strain
IRCT20191230045950N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2017
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of busulfan, sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Left ventricular global longitudinal strain. Started Sep 2017; status: completed.
02
Drugs
busulfan
Beyond the preview
Go deeper on IRCT20191230045950N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191230045950N1.